Dyadic International Inc
DYAI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001213809
In the last 90 days, Dyadic International Inc insiders filed 0 open-market purchases and 2 sales; 39 institutions reported holding it in 13F filings for Q2 2026, worth $4.14M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Dyadic International Inc changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 41 | 34 | −7 |
| Shares | 5.12M | 5.06M | −59.6K (−1.2%) |
| Value | $8.33M | $6.83M | −$1.50M (−18.0%) |
New holders (1)
Institutions that held Dyadic International Inc at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| XTX Topco Ltd | 12,402 | $16.7K | 0.00% |
Sold out (8)
Institutions that held Dyadic International Inc at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Jane Street Group, LLC | 25,711 | $45.0K |
| Millennium Management LLC | 16,193 | $28.3K |
| Wolverine Trading, LLC | 14,263 | $25.4K |
| Two Sigma Securities, LLC | 14,037 | $24.6K |
| Thompson Davis & Co., Inc. | 12,000 | $21.0K |
| Simplex Trading, LLC | 4,407 | $7.00K |
| UBS Group AG | 274 | $480 |
| SBI Securities Co., Ltd. | 70 | $123 |